NEW YORK, NY / ACCESSWIRE / September 6, 2019 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against CVS Health Corporation (“CVS” or the “Company”) (CVS) and certain of its officers, on behalf of shareholders who acquired CVS shares in exchange for their Aetna shares in connection with CVS’s acquisition of Aetna on November 28, 2018. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1933. On May 20, 2015, CVS Pharmacy, Inc., a wholly owned subsidiary of CVS, entered into a merger agreement to acquire Omnicare, Inc., a provider of pharmaceuticals and other pharmacy services to long-term care facilities (“LTC”) (e.g., assisted living, skilled nursing, and senior centers) and a provider of specialty pharmacy and commercialization services for the bio-pharmaceutical industry.

source https://finance.yahoo.com/news/investor-alert-cvs-health-corporation-143300674.html?.tsrc=rss